Slide 1: Report for quarter 4 and full-year 2025
Report for quarter 4 and full-year 2025 January 22, 2026
Slide 2: Ulrika Kolsrud, President and CEO
Ulrika Kolsrud President and CEO
Slide 3: Highlights Q4 2025
Highlights Q4 2025 Organic sales growth EBITA excl. IAC • Organic sales decline mainly due to lower prices • Higher market shares in >65 % of retail branded sales +4.6% SEK • Strong growth in strategic segments -1.1% Organic: 5,117m • Higher profit and margins, strong cash flow +3.8% +3% • New organ
Slide 4: Health & Medical
Health & Medical Business highlights • Positive organic sales growth • Volume growth both for Incontinence Products and Medical Solutions • Growth across therapy areas – Wound Care, Compression and Orthopedics • Launch of TENA Proskin Flex with enhanced ComfiStretch belt • Upgraded Cutimed® Siltec®
Slide 5: Consumer Goods
Consumer Goods Business highlights • Higher market shares in >65 % of branded sales • Strong volume growth for Incontinence Products • Good underlying growth in Feminine Care • Baby Care sales down but growth for Libero • Consumer Tissue sales down but growth in Brands • High launch activity – TENA
Slide 6: Professional Hygiene
Professional Hygiene Business highlights • Organic sales declined due to continued challenging market conditions • Strong growth of premium products • Launch of Tork PeakServe® Automatic Hand Towel Dispenser • Launch of Tork Reflex Dispenser with Natural Wiping Paper • Volume fighters to compete acr
Slide 7: Strong development of product superiority
Strong development of product superiority 73% 64% 59% 56% 40% 2017 2020 2023 2024 2025
Slide 8: Fredrik Rystedt, EVP and CFO
Fredrik Rystedt EVP and CFO & essity
Slide 9: Sales development
Sales development Organic sales growth: SEK 37.8bn -0.2% -0.9% -7.1% Health & Medical +0.7% SEK 34.7bn + Health & Medical - Health & Medical • Incontinence Health Care +0.5% - Consumer Goods - Consumer Goods - Professional Hygiene - Professional Hygiene • Medical Solutions +1.1% Consumer Goods -2.0%
Slide 10: Margin development
Margin development +180bps -40bps +20bps 14.7% 13.1% - Lower sales prices EBITA margin excl. IAC: + Lower COGS Health & Medical 18.7% Consumer Goods 12.9% Professional Hygiene 19.5% Q4 2024 Impact Gross A&P SG&A Q4 2025 Profit Margin (excl. A&P) Report for Quarter 4 and full-year 2025 10
Slide 11: Operating cash flow
Operating cash flow 6.5 SEKbn 5.9 5.3 4.3 4.4 3.8 3.2 3.3 1.5 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Report for Quarter 4 and full-year 2025 11
Slide 12: Balance sheet
Balance sheet SEKbn 70 5 62.9 4,5 60 53.7 4 50 3,5 3 40 3.1 30.8 2,5 30 26.5 2 20 2.0 1,5 1 10 1.2 1.0 0,5 0 0 2022 2023 2024 2025 Net Debt, SEKbn Net Debt / EBITDA excl. IAC Report for Quarter 4 and full-year 2025 12
Slide 13: Full-year 2025
Full-year 2025 Stability and high profitability in a challenging environment Net sales Organic sales growth SEK +4.6% 138,494m +0.9% Organic: +3.8% EBITA excl. IAC EBITA margin excl. IAC SEK 19,572m 14.1% 13
Slide 14: EPS Growth
EPS Growth +58% CAGR +6% SEK 19.4 per share SEK 12.3 per share 20171) 2025 Earnings per share excl. IAC and amortization of acquisition-related intangible assets 1) Adjusted for US Tax reform 2017
Slide 15: Dividend SEK 8.75 per share
Dividend Proposed dividend 20251) Dividend, SEK per share 8.751) 8.25 7.75 7.00 7.25 6.75 6.25 5.75 SEK 8.75 per share +6% 2018 2019 2020 2021 2022 2023 2024 2025 1) Board of Directors proposal Report for Quarter 4 and full-year 2025 15
Slide 16: Ulrika Kolsrud, President and CEO
Ulrika Kolsrud President and CEO
Slide 17: Summary
Summary • Q4 – a strong finish to 2025 – Strong innovation delivery – Growth in strategic segments and higher market shares – High profit and margins – Stable delivery in a challenging market • Initiatives to accelerate profitable volume growth – New organisation – Cost save program – Feminine care
Slide 18: Priorities 2026
Priorities 2026 Drive profitable volume growth • Customers and consumers first! • Grow market shares, supported by innovation • Integrate Edgewell acquisition to strengthen Personal Care business in North America • Execute SG&A savings to invest in profitable growth and deliver COGS savings • Increa
Slide 19: Welcome! Capital Markets Day 2026
Save the date Essity’s Capital Markets Day Essity Capital Markets Day 2026 May 7, 2026 at our office in Gothenburg, Sweden Welcome!
Slide 20: Forward-looking statements disclaimer
This presentation may contain forward-looking statements. Such statements are based on our current expectations and are subject to certain risks and uncertainties that could negatively affect our business. Please read our most recent annual report for a better understanding of these risks and uncert
Slide 21: Q&A
Q&A 21
Slide 22: Essity
ée> eSsity TORK] Tena €Cutimed’ Libero wv wy ® SS oS